查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1883804

全球冠狀動脈支架市場

Coronary Stents
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 342 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年，全球冠狀動脈支架市場規模將達到136億美元。

2024年全球冠狀動脈支架市場規模估計為99億美元，預計到2030年將達到136億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為5.4%。本報告分析的細分市場之一－藥物釋放型支架，預計複合年成長率為5.6%，到分析期末將達到96億美元。其他類型支架的複合年成長率預計在分析期間為5.1%。

美國市場規模估計為28億美元，而中國市場預計將以7.2%的複合年成長率成長。

據估計，2024年美國冠狀動脈支架市場規模將達28億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到11億美元，在2024年至2030年的分析期間內，年複合成長率（CAGR）為7.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的年複合成長率分別為4.3%和4.7%。在歐洲，德國的年複合成長率預計約為4.8%。

全球冠狀動脈支架市場－主要市場趨勢與促進因素概述

冠狀動脈支架是一種小型可擴張的管狀裝置，插入狹窄或阻塞的冠狀動脈中，以恢復心臟的血液供應。這些裝置在冠狀動脈疾病（CAD）的治療中發揮著至關重要的作用，冠狀動脈疾病是全球發病率和死亡率的主要原因之一。支架有助於在血管成形術等手術後保持動脈暢通，血管成形術使用球囊擴張動脈。冠狀動脈支架有多種類型，包括裸金屬支架（BMS）、藥物釋放型支架（DES）和生物可吸收支架。藥物釋放型支架塗上藥物以防止動脈再血管再阻塞，而生物可吸收支架在支撐動脈後會逐漸溶解。

冠狀動脈支架的研發和發展得益於醫療技術和材料科學的進步。早期的裸金屬支架雖然能夠提供結構支撐，但卻面臨較高的血管再阻塞（動脈血管再阻塞）風險。藥物釋放型支架的出現顯著降低了這種風險，因為它能夠釋放抑制疤痕組織生長的抗增殖藥物。近年來，生物可吸收支架的研發取得了進展，這種支架在提供暫時支撐後即可溶解，從而有望減少長期併發症。支架設計的創新，例如更細的支架樑和更高的柔韌性，提高了支架的輸送性和性能，從而提升了安全性和有效性。此外，診斷影像技術的進步也提高了支架植入的精確度，進一步改善了患者的預後。

冠狀動脈支架市場的成長受多種因素驅動。首先，人口老化、不健康的生活方式以及肥胖和糖尿病發病率上升等因素導致冠狀動脈疾病盛行率不斷增加，從而推動了支架需求的成長。其次，支架技術的進步，包括新一代藥物釋放型和生物可吸收支架的研發，透過提高安全性和有效性，推動了市場成長。第三，新興經濟體醫療基礎設施的完善和先進醫療服務的普及，促進了冠狀動脈支架的廣泛應用。此外，患者和醫療服務提供者對微創手術治療冠狀動脈疾病（CAD）益處的認知不斷提高，也促進了市場擴張。最後，政府的支持政策、醫療資金和報銷體系，促進了先進支架技術的應用，從而改善了患者照護並推動了市場成長。

部分：

依類型（藥物釋放型支架、其他類型）、依最終使用者（醫院、門診手術中心、其他最終使用者）

受訪公司範例

  • Abbott Cardiovascular
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • BIOTRONIK SE &Co. KG
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • Elixir Medical Corporation
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Microport Scientific Corporation
  • Sahajanand Medical Technologies Ltd.
  • Terumo Europe NV
  • Translumina GmbH

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在國、製造地以及進出口（成品和OEM產品）情況，預測企業競爭格局的變化。這種複雜多變的市場現實將對競爭對手產生多方面的影響，包括銷貨成本增加、盈利下降和供應鏈重組，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 中東
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP-1148

Global Coronary Stents Market to Reach US$13.6 Billion by 2030

The global market for Coronary Stents estimated at US$9.9 Billion in the year 2024, is expected to reach US$13.6 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Drug Eluting Stents, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.6 Billion by the end of the analysis period. Growth in the Other Types segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 7.2% CAGR

The Coronary Stents market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Coronary Stents Market - Key Trends & Drivers Summarized

Coronary stents are small, expandable tubes that are inserted into narrowed or blocked coronary arteries to restore blood flow to the heart. These devices play a crucial role in the treatment of coronary artery disease (CAD), which is a leading cause of morbidity and mortality worldwide. Stents help to keep the arteries open after procedures such as angioplasty, where a balloon is used to widen the artery. There are different types of coronary stents, including bare-metal stents (BMS), drug-eluting stents (DES), and bioresorbable stents. Drug-eluting stents are coated with medication that helps prevent the re-narrowing of the artery, while bioresorbable stents gradually dissolve after providing support to the artery.

The development and evolution of coronary stents have been driven by advancements in medical technology and materials science. Early bare-metal stents provided structural support but were associated with a higher risk of restenosis, or re-narrowing of the artery. The introduction of drug-eluting stents significantly reduced this risk by releasing antiproliferative drugs that inhibit the growth of scar tissue. More recently, bioresorbable stents have been developed to provide temporary support and then dissolve, potentially reducing long-term complications. Innovations in stent design, such as thinner struts and enhanced flexibility, have improved the deliverability and performance of stents, making them safer and more effective. Furthermore, advances in imaging and diagnostic technologies have enhanced the precision of stent placement, improving patient outcomes.

The growth in the coronary stent market is driven by several factors. Firstly, the increasing prevalence of coronary artery disease, driven by factors such as aging populations, unhealthy lifestyles, and rising rates of obesity and diabetes, is boosting the demand for stents. Secondly, advancements in stent technology, including the development of next-generation drug-eluting stents and bioresorbable stents, are driving market growth by offering improved safety and efficacy. Thirdly, the expansion of healthcare infrastructure and access to advanced medical treatments in emerging economies is increasing the adoption of coronary stents. Additionally, the growing awareness among patients and healthcare providers about the benefits of minimally invasive procedures for treating CAD is supporting market expansion. Lastly, supportive government policies, healthcare funding, and reimbursement frameworks are facilitating the adoption of advanced stent technologies, ensuring better patient care and driving market growth.

SCOPE OF STUDY:

The report analyzes the Coronary Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Drug Eluting Stents, Other Types); End-User (Hospitals, Ambulatory Surgery Centers, Other End-Users)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 60 Featured) -

  • Abbott Cardiovascular
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • Elixir Medical Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Microport Scientific Corporation
  • Sahajanand Medical Technologies Ltd.
  • Terumo Europe N.V.
  • Translumina GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Coronary Artery Disease (CAD) - A Perspective
    • Types of Coronary Stents
    • Competitive Scenario
    • Players Bet Heavily on Product Advances to Stay Competitive on Coronary Stents Market
    • Coronary Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Global Economic Update
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Market Prospects and Outlook
    • Global Coronary Stents Market Remains Hale & Hearty with Incredible Vigor
    • Drug-Eluting Stents: Segment at the Heart of Global Coronary Stents Market
    • Decent Contribution from Bioresorbable Scaffolds & Bare Metal Stents
    • North America Rules Coronary Stents Market, while Asia-Pacific Pumps Growth Boosters
    • China's Effective Treatments' Clinical Trials in Progress to Augment the Market Size
    • Market Restraints & Challenges
    • Market Opportunities
    • Technological Advancements
    • Product Launches
    • Strategic Collaborations
    • Rising Popularity of Drug-Eluting Stents
    • Focus on Personalized Medicine
    • The Medical Tourism Trend
    • Relocation of Manufacturing Operations to Low-cost Countries
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Unprecedented Spike in CAD Cases Drives the Demand for Coronary Stents
    • Global Annual Medical Cost of CVD in the United States: 2015-2030
    • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Ageing Demographics and Longer Life Expectancy Bolsters Market Growth
    • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • The Rise in Minimally Invasive Surgeries Spur Market Expansion
    • Rising Middle Class Population Aids Growth
    • Global Middle Class Population (in Millions) by Geographic Region: 2010, 2020E & 2030P
    • Rising Healthcare Expenditure: Opportunities in Store
    • Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
    • Risk of CAD in Obesity Offers Prospects for Coronary Stenting
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Diabetics at Higher Risk of Heart Diseases to Propel Market Demand
    • Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040
    • New Drug-Eluting Stent for Treatment of Diabetic People with Coronary Heart Disease
    • The Hypertension-Cholesterol Link to Drive the Demand for Coronary Stents
    • Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
    • Growing Awareness Levels
    • Uptake of Advanced Imaging Techniques
    • Supportive Reimbursement Policies
    • Innovative Device with Potential to Take Coronary Stent Technology to Next Level
    • New Nitric Oxide-Producing Stent Coatings to Prevent Thrombosis and Restenosis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Coronary Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • JAPAN
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • CHINA
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • EUROPE
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Coronary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • FRANCE
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • GERMANY
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Coronary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • INDIA
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 134: Middle East Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Middle East Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Middle East 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 137: Middle East Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Middle East Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Middle East 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • AFRICA
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 140: Africa Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Africa Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Africa 15-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2015, 2025 & 2030
    • TABLE 143: Africa Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Africa Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Africa 15-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION